Mineralys Therapeutics, Inc. (MLYS) vs SELLAS Life Sciences Group, Inc. (SLS)
Mineralys Therapeutics, Inc. and SELLAS Life Sciences Group, Inc. are both Biotechnology companies. Mineralys Therapeutics, Inc. and SELLAS Life Sciences Group, Inc. are of similar size ($2.4B and $2.4B). Across the 9 metrics below, SELLAS Life Sciences Group, Inc. leads on 7 and Mineralys Therapeutics, Inc. on 2.
Valuation
Profitability
| Metric | MLYS | SLS | Biotechnology median |
|---|---|---|---|
| Gross margin | — | 0.00% | 65.16% |
| Operating margin | 0.00% | 0.00% | 0.00% |
| Net margin | 0.00% | 0.00% | 0.00% |
| Free cash flow margin | 0.00% | 0.00% | 0.00% |
| Return on equity | (80.88%) | (39.63%) | (57.72%) |
| Return on assets | (69.67%) | (36.54%) | (49.22%) |
| Return on invested capital | 0.00% | 0.00% | 0.00% |
Growth
Health
Dividend
Size
Any metric, up to five companies and an Excel export Powerpack